Results 131 to 140 of about 1,378,916 (231)

Soluble Urokinase Receptor as a Promising Marker for Early Prediction of Outcome in COVID-19 Hospitalized Patients. [PDF]

open access: yesJ Clin Med, 2021
Napolitano F   +11 more
europepmc   +1 more source

Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator‐associated pneumonia?

open access: yes, 2017
BackgroundSoluble urokinase plasminogen activator receptor (suPAR) is a biomarker that is increasingly used for evaluation of systemic inflammation. This study was performed to investigate whether suPAR may possess a diagnostic value in patients with ...
Adiyaman, Firat   +9 more
core   +1 more source

Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events

open access: yes, 2011
The soluble urokinase plasminogen activator receptor (suPAR) is a plasma marker of low grade inflammation and has been associated with cardiovascular risk.
Linneberg, Allan René   +24 more
core   +1 more source

BIOCHEMICAL MARKERS OF ENDOTHELIAL DYSFUNCTION AND HEMOSTASIS IN ATHEROSCLEROSIS AND THE GENES RESPONSIBLE FOR THEIR REGULATION

open access: yesАтеросклероз, 2017
The review systematized modern concepts of markers of endothelial dysfunction and disorders of hemostasis (asymmetric dimethylarginine, endothelin 1, adhesive ICAM and VCAM molecules, apolipoproteins, antithrombin III, receptor of urokinase plasminogen ...
E. V. Stryukova   +2 more
doaj  

Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer

open access: yes, 2000
Perturbation of adhesive interactions at cell-substratum and cell-cell contact sites is a critical event in the multistep process of cancer invasion. Recent studies indicate that the urokinase receptor (uPAR) is associated in large molecular complexes ...
Fontana L   +9 more
core  

Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)

open access: yes, 1999
Activation of plasminogen to plasma is inhibited by preventing the binding of a receptor binding form of urokinase-type plasminogen activator to a urokinase-type plasminogen activator receptor in a mammal, thereby preventing the urokinase-type ...
Pollanen,, Jari   +20 more
core  

Dattabase Information from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis

open access: yes, 2009
Dattabase Information from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung ...
Mario De Rosa (15040481)   +12 more
core   +1 more source

Urokinase receptor expression is upregulated by cell culture sparsity in breast cancer cell line BT20

open access: yes, 1999
Background: The processes of tumour cell migration and invasion are enhanced by urokinase activity mediated by the urokinase receptor on the cell surface.
Yellowlees, D.   +3 more
core  

Home - About - Disclaimer - Privacy